Westside Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$83.8K Hold
5,000
0.02% 366
2025
Q1
$76.9K Hold
5,000
0.02% 343
2024
Q4
$110K Hold
5,000
0.02% 299
2024
Q3
$81.3K Sell
5,000
-235
-4% -$3.82K 0.02% 337
2024
Q2
$74.4K Hold
5,235
0.02% 334
2024
Q1
$73.9K Buy
5,235
+235
+5% +$3.32K 0.02% 328
2023
Q4
$52.2K Sell
5,000
-500
-9% -$5.22K 0.01% 355
2023
Q3
$56.1K Hold
5,500
0.02% 326
2023
Q2
$41.4K Sell
5,500
-1,000
-15% -$7.53K 0.01% 380
2023
Q1
$58.9K Hold
6,500
0.02% 338
2022
Q4
$45.6K Hold
6,500
0.11% 130
2022
Q3
$40.4K Sell
6,500
-520
-7% -$3.23K 0.1% 137
2022
Q2
$42.3K Hold
7,020
0.1% 138
2022
Q1
$51.7K Sell
7,020
-500
-7% -$3.68K 0.11% 124
2021
Q4
$44.1K Hold
7,520
0.1% 130
2021
Q3
$53.6K Hold
7,520
0.12% 117
2021
Q2
$54.5K Sell
7,520
-1,650
-18% -$12K 0.13% 116
2021
Q1
$75K Sell
9,170
-5,300
-37% -$43.4K 0.2% 91
2020
Q4
$102K Sell
14,470
-150
-1% -$1.06K 0.28% 66
2020
Q3
$95.5K Buy
14,620
+2,920
+25% +$19.1K 0.04% 64
2020
Q2
$118K Sell
11,700
-1,000
-8% -$10.1K 0.07% 47
2020
Q1
$86.2K Buy
+12,700
New +$86.2K 0.06% 62
2019
Q2
$14.6K Buy
+5,208
New +$14.6K 0.03% 66
2018
Q4
$160K Sell
10,124
-230
-2% -$3.62K 0.06% 171
2018
Q3
$221K Sell
10,354
-1,950
-16% -$41.6K 0.07% 141
2018
Q2
$300K Sell
12,304
-1,225
-9% -$29.9K 0.11% 126
2018
Q1
$227K Sell
13,529
-1,600
-11% -$26.8K 0.12% 145
2017
Q4
$289K Sell
15,129
-4,425
-23% -$84.6K 0.16% 129
2017
Q3
$308K Sell
19,554
-11,110
-36% -$175K 0.19% 109
2017
Q2
$956K Sell
30,664
-2,436
-7% -$75.9K 0.62% 39
2017
Q1
$1.06M Buy
33,100
+16,430
+99% +$527K 0.51% 29
2016
Q4
$573K Buy
+16,670
New +$573K 0.39% 36